Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Álvaro Urbano
Observed name:
Alvaro Urbano
Institutions:
Hospital Clínic de Barcelona,
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer,
Universitat de Barcelona
Observed institutions:
Institut Català d'Oncologia,
Hospital Clínic de Barcelona,
Hospital Universitario Virgen del Rocío,
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer,
Universitat de Barcelona
OpenAlex ID:
A5111917338
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐versus‐host disease after allogeneic transplantation
2005
·
José A. Pérez‐Simón
, María Díez‐Campelo
, et al.
·
British Journal of Haematology
·
116
Autologous Haematopoietic Stem Cell Transplantation for Refractory Crohn’s Disease: Efficacy in a Single-Centre Cohort
2017
·
Alicia López-García
, Montserrat Rovira
, et al.
·
Journal of Crohn s and Colitis
·
77
Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease
2015
·
Aranzazu Jauregui-Amezaga
, Montserrat Rovira
, et al.
·
Gut
·
75
Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment impacting outcomes
2019
·
Pedro Puerta-Alcalde
, Celia Cardozo
, et al.
·
Bone Marrow Transplantation
·
55
Fatal Immune Hemolytic Anemia Following Allogeneic Stem Cell Transplantation: Report of 2 Cases and Review of Literature
2013
·
Jordina Rovira
, Joan Cid
, et al.
·
Transfusion Medicine Reviews
·
41
Risk Factors for Mortality in Hematopoietic Stem Cell Transplantation Recipients with Bloodstream Infection: Points To Be Addressed by Future Guidelines
2021
·
Pedro Puerta-Alcalde
, Mariana Chumbita
, et al.
·
Transplantation and Cellular Therapy
·
25
A Subcutaneously Administered Investigational RNAi Therapeutic (ALN-CC5) Targeting Complement C5 for Treatment of PNH and Complement-Mediated Diseases: Preliminary Phase 1/2 Study Results in Patients with PNH
2016
·
Anita Hill
, Anna Gaya Valls
, et al.
·
Blood
·
25
Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain Metastasis
2019
·
Tomás Pascual
, Blanca Gonzalez-Farre
, et al.
·
JCO Precision Oncology
·
24
PDF
Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry
2017
·
Ana Villegas
, Ramiro Núñez
, et al.
·
Annals of Hematology
·
20
Influence of the Intensity of the Conditioning Regimen on the Characteristics of Acute and Chronic Graft Versus Host Disease after Allogeneic Transplantation.
2004
·
Maria Diez-Campelo
, Jose A. Perez-Simon
, et al.
·
Blood
·
18
Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T‐cell redirecting immunotherapy
2024
·
Aintzane Zabaleta
, Noemi Puig
, et al.
·
American Journal of Hematology
·
11
PDF
Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica
2011
·
Luis Felipe Casado
, José Antonio García Marco
, et al.
·
Gaceta Sanitaria
·
10
m-EASIX (better than EASIX) predicts severe CAR T-cell toxicities, worse overall survival, and discriminates cytokine release syndrome from sepsis
2026
·
Ana Belén Moreno-Castaño
, Sara Fernández
, et al.
·
Frontiers in Immunology
·
5
PDF
Risk-Factors for Acute Graft-Versus-Host Disease and Survival After Hematopoietic Cell Transplantation From Siblings and Unrelated Donors – An Analysis of the CIBMTR
2010
·
Madan Jagasia
, Mukta Arora
, et al.
·
Blood
·
4
Chronic Graft-Versus-Host Disease Risk Score: A CIBMTR Analysis
2010
·
Mukta Arora
, John P. Klein
, et al.
·
Blood
·
3
Risk Factors for Major Transplant Related Outcomes In Pediatric Patients with Chronic Graft-Versus-Host Disease
2010
·
David A. Jacobsohn
, Mukta Arora
, et al.
·
Blood
·
1
Evaluación económica de rituximab en combinación con udarabina y ciclofosfamida en comparación con udarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica
2016
·
Luis Felipe Casado
, José Antonio García Marco
, et al.
Periodic Evaluation Of The Clone Size Is Mandatory In PNH: Study Of The Spanish Cohort Of The International PNH Registry
2013
·
Ana Villegas
, Ana Gaya
, et al.
·
Blood
Allogeneic Stem-Sell Transplantation In Multiple Myeloma In Real Practice: Long-Term Results From a Single Institution
2013
·
Raquel Jiménez
, Laura Rosiñol
, et al.
·
Blood
Fe de errores de "Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica" Erratum to "Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia"
2011
·
Luis Felipe Casado
, José Antonio García Marco
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia
2011
·
Luis Felipe Casado
, José Antonio García Marco
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
Differential Gene Expression Involved In Angiogenesis, Metabolism, Cell Proliferation and Self-Renewal and Pluripotency In Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
2010
·
Jose F Falantes
, Cristina Calderón
, et al.
·
Blood
Immune Status In Patients with Chronic Lymphocytic Leukemia and Sustained Complete Remission: A Multiparametric Analysis
2010
·
Kate E Hodgson
, Gerardo Ferrer
, et al.
·
Blood
Long Remission Are Possible after Non Myeloablative Transplant in Patients with Follicular Non-Hodgkin’s Lymphoma (NHL): Results of Two Prospectives Multicenter Trials.
2006
·
María-Dolores Caballero
, Rodrigo Martino
, et al.
·
Blood
Donor Lymphocyte Transfusion (DLT) in the Treatment of Relapsed CML after Allogeneic PBSCT - A Retrospective Analysis of 346 Patients by the EBMT Chronic Leukemia Working Party.
2005
·
Christoph Schmid
, Anja v. Biezen
, et al.
·
Blood
Show more works
View as search
Works count:
25
Citation count:
510
H-index:
11
I10-index:
12
Year
Topic
Type